Gene Cell Nano
GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.
News
- MSCA Postdoctoral Fellowship awarded for the development of nanoparticles for treating ocular diseases
- Cell-Secreted Vesicles: Methods and Protocols
- New Publication: Clinical-Grade Patches as a Medium for Enrichment of Sweat-Extracellular Vesicles and Facilitating Their Metabolic Analysis
- Tutkimuksen lippulaivat: Suomi tarvitsee korkeatasoista perustutkimusta ja lisää kansainvälisiä osaajia
- Seppo Ylä-Herttuala secures a 1.3 million Horizon Europe grant for the development of gene therapy for a rare cardiac disease
Events
- Research Seminar Afternoon of the CVD Research Community the and GeneCellNano Flagship 7.6.2023
- Pharmacy Research Day in Kuopio 24.5.2023 (webinar)
- The 2nd Annual Meeting of the GeneCellNano Flagship Consortium
- The 2nd FISEV Seminar, 6.2.2023 in Kuopio
- Healthy environment – healthy people project: open discussion event
GeneCellNano is an interdisciplinary community of top experts specialized in biological Advanced Therapy Medicinal Products (ATMP) and nanotechniques linked with their management.